Nexgel Inc (NASDAQ: NXGL) is a hydrogel-based manufacturing company that produces consumer products and contract-manufactured goods using water-based gel technology. Revenue comes from two streams: direct-to-consumer product sales through Amazon and Shopify marketplaces, and contract manufacturing for third-party customers, both conducted on a purchase-order basis with no minimum commitments. The company operates from a combined corporate office and manufacturing facility and had 19 full-time employees as of December 31, 2025. Selling, general and administrative expenses were $7,859 thousand for FY2025, up 26.3% from $6,224 thousand in FY2024. Cash and cash equivalents stood at $317 thousand as of December 31, 2025, down from $1,807 thousand at December 31, 2024, with net cash used in operating activities of $1,311 thousand for FY2025. The company is also developing medical device products including NEXDrape, a hydrogel-based surgical drape, and NEXDerm, a hydrogel adhesive tape for securing central lines, both pending FDA 510(k) clearance.
Hydrogel-based consumer products sold through Amazon and Shopify; contract manufacturing services for third-party customers; medical device pipeline including NEXDrape (hydrogel surgical drape, pre-FDA clearance) and NEXDerm (hydrogel adhesive tape for central lines and IV devices, pre-FDA clearance) as of the FY2025 10-K.
Transactional revenue from consumer product sales via Amazon and Shopify marketplaces, plus contract manufacturing fees from third-party customers. All sales are made on a purchase-order basis with no contracts or minimum purchase commitments in either business segment (per FY2025 10-K).
End consumers purchasing through Amazon and Shopify; contract manufacturing customers across unspecified end markets; medical professionals as the target end market for pipeline device products NEXDrape and NEXDerm (per FY2025 10-K).
The filing excerpts do not specify geographic revenue breakdown beyond reliance on Amazon and Shopify marketplaces for consumer product distribution.
Loading...